Tapering weighs on DAX

The German equity market is offside as tapering fears outweigh a strong ZEW report, which measures investment sentiment.

The DAX is trading at 9144, down 0.15%, as global equities feel the pressure ahead of an anticipated reduction of the $85 billion bond-buying scheme tomorrow. This fall is in spite of the ZEW report which came in at 62 in December, the highest reading since April 2006 and smashing the expectation of 55.3. The ZEW report for the eurozone as a whole came in at 68.3 in December, following a consensus for a reading of 60.9.

The decision not to trim the stimulus package in September took some traders by surprise, and they are clearly determined this will not happen again. Also, since September the unemployment rate in the US has dropped to 7%, and the US central bank has stated that a sizeable reduction in the jobless rate would lead to tapering.

Equities are likely to continue to be quiet ahead of the announcement from the Fed. If a reduction in the bond-buying scheme is announced, we could see the market head towards the 9000 level.

Germany 30

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.